Maternal preexisting type 2 diabetes (T2D) and gestational diabetes mellitus (GDM) diagnosed by 26 weeks' gestation have been associated with increased risk of autism spectrum disorder (ASD) in offspring.
1 However, little is known about ASD risk associated with maternal preexisting type 1 diabetes (T1D). We extend previous observations by examining the risk of ASD in offspring associated with maternal T1D, T2D, and GDM.
Methods | This retrospective cohort study included singleton children born at 28 to 44 weeks' gestation in Kaiser Permanente Southern California (KPSC) hospitals from January 1, 1995, through December 31, 2012. Children were tracked through electronic health records from age 1 year until the first date of the following: clinical diagnosis of ASD, last date of continuous KPSC membership, death, or study end date (December 31, 2017) . The KPSC institutional review board approved this study and provided waiver of participant consent. Methods to identify ASD, T2D, and GDM exposure were described previously.
1 GDM exposure was divided into diagnosis by or after 26 weeks' gestation based on a prior finding that risk of ASD was elevated for exposure to GDM by 26 weeks. 1 T1D was identified using the algorithm developed for electronic health records data 2 and confirmed by prescription of insulin during pregnancy. Potential confounders were birth year, maternal age at delivery, parity, education, selfreported race/ethnicity, median family household income based on residence census tract, history of comorbidity (≥1 diagnosis of heart, lung, kidney, or liver disease; cancer), and child's sex. Data on maternal smoking and obesity (measured by prepregnancy body mass index [calculated as weight in kilograms divided by height in meters squared]) were available beginning after 2006 (on 36% of the cohort). The missing indicator method was used to additionally adjust for these covariates. Cox regression was used to estimate hazard ratios (HRs) adjusting for potential confounders. All mothers with T1D and T2D, but only 29% of those with GDM, were dispensed antidiabetic medications during pregnancy. Potential risk associated with antidiabetic medication exposure was assessed in the GDM group, adjusting for potential confounders plus the gestational age at GDM diagnosis. SAS Enterprise Guide (SAS Institute), version 5.1, and R (R Foundation), version 3.4.3 (64 bit), were used for data analysis. A 2-sided P value less than .05 was considered significant.
Results | Of 419 425 children (boys, 51%) meeting study criteria, 621 were exposed to maternal T1D, 9453 to maternal T2D, 11 922 to GDM diagnosed by 26 weeks' gestation, and 24 505 to GDM diagnosed after 26 weeks' gestation. During a median follow-up of 6.9 years (interquartile range, 3.4-11.9), 5827 children were diagnosed with ASD. Unadjusted average annual ASD incidence rates per 1000 children were 4.4 for exposure to T1D; 3.6 for T2D; 2.9 for GDM by 26 weeks; 2.1 for GDM after 26 weeks; and 1.8 for no diabetes. The Figure Discussion | Among the 3 main types of diabetes complicating pregnancy, the risk of ASD in offspring was elevated in mothers with T1D, T2D, and GDM diagnosed by 26 weeks' gestation compared with no diabetes. These results add new information on T1D and extend previous findings 1 for preexisting T2D and GDM. GDM diagnosed after 26 weeks' gestation was not associated with excess risk compared with no diabetes. These results suggest that the severity of maternal diabetes and the timing of exposure (early vs late in pregnancy) may be associated with the risk of ASD in offspring of diabetic mothers. The potential role of maternal glycemia; other features of T1D such as autoimmunity and genetic factors 3,4 ; prematurity; and neonatal hypoglycemia 5 remains to be explored. Confounding due to paternal risk factors and other intrauterine and postnatal exposures could not be assessed. Abbreviations: ASD, autism spectrum disorder; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); HR, hazard ratio; T1D, type 1 diabetes; T2D, type 2 diabetes. a ASD includes autistic disorders, Asperger syndrome, or pervasive developmental disorder not otherwise specified. b Estimated by Cox regression models in which family was specified as a random effect to control for potential correlation due to multiple siblings born to the same mother. Potential confounders were birth year, maternal age, parity, education, median household income based on census tract of residence, self-reported race/ethnicity, history of comorbidity (Ն1 diagnosis of heart, lung, kidney, or liver disease; cancer); and sex of the child. Race/ethnicity was self-reported. Race/ethnicity was included in this study as a potential confounder because it was associated with maternal diabetes and child's ASD risk. c Additionally adjusted for smoking and prepregnancy BMI. About 36% of the cohort had data on smoking during pregnancy and prepregnancy BMI because these variables were routinely recorded in the electronic medical records after 2006. To preserve power for the primary exposures, a "missing" category was used for individuals with missing smoking information and a "missing" indicator variable was created for individuals with missing prepregnancy BMI in the multivariable adjusted analysis. Prepregnancy BMI was treated as a continuous variable in the adjustment. Second, we have concerns regarding the study design. Venkataramani and colleagues 1 made use of a natural experiment, an often powerful design in observational studies, and compared career NFL players with NFL replacement players, the latter of whom played in the league for a limited time during a strike. The authors suggested this design better isolated the effect of playing in the NFL because replacement players are capable of playing professionally and thus are otherwise similar to career players. However, the NFL replacement players may be a diverse group. For many, their general mortality risk factors, such as income, diet, and exercise, may diverge considerably from those of career NFL players. On the other hand, some NFL replacement players may have more similar exposure to league-specific factors (eg, repeated head trauma) than the study suggested because of ongoing participation in football in other leagues. Thus, the study findings may be biased away from the null (in the case of general mortality risk factors) or toward the null (in the case of league-specific risk factors). Third, the larger issue is whether isolating the effect of playing in the NFL is a useful approach. Prevailing hypotheses about the effects of head trauma posit that it is the accumulation of repeated traumas that is most consequential for health.
5 As such, the real question is whether increased longevity of playing American football, rather than playing in the NFL per se, is associated with mortality or other health outcomes.
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